## Understanding PET Scan Principles and Clinical Application ### Metabolic vs. Morphological Imaging **Key Point:** PET imaging detects metabolic activity (glucose metabolism via FDG uptake) rather than anatomical structure. This is fundamentally different from CT, which provides morphological detail. In this colorectal cancer recurrence scenario, PET-CT is particularly valuable because: 1. **Early detection of recurrence**: PET can identify metabolically active tumor cells before they cause morphological changes visible on CT 2. **Sensitivity in small lesions**: While PET has lower spatial resolution than CT (~5–7 mm), it compensates with superior sensitivity for detecting metabolically active disease 3. **Complementary role**: PET-CT combines both modalities—PET for function, CT for anatomy—making it ideal for staging and surveillance ### Why This Answer Is Correct Option 3 accurately reflects the clinical utility of PET in cancer surveillance. Elevated CEA with normal CT imaging is a classic scenario where PET excels: it can reveal occult metastatic disease through FDG avidity when morphology appears normal. This is the **single best answer** because it captures the fundamental advantage of PET—metabolic detection—in a real clinical context. ### Comparison with Other Modalities | Modality | Strength | Limitation | |----------|----------|----------| | **PET** | Metabolic activity, early recurrence detection | Lower spatial resolution (~5–7 mm) | | **CT** | Excellent spatial resolution, anatomical detail | May miss small metabolically active lesions | | **PET-CT** | Combines both metabolic and morphological data | Higher cost, radiation dose | | **Skeletal scintigraphy** | Sensitive for osteoblastic metastases | Lower specificity, poor spatial resolution | ### Clinical Pearl **High-Yield:** In cancer surveillance with rising tumor markers but normal conventional imaging, PET-CT is the investigation of choice. This scenario—elevated CEA + normal CT—is a classic NEET PG vignette for PET utility. ### Mechanism of FDG Uptake FDG (fluorodeoxyglucose) is a glucose analogue labeled with fluorine-18. Malignant cells have higher glucose metabolism (Warburg effect) and thus accumulate more FDG. However, **inflammatory and infectious lesions also show FDG uptake**, which is why increased uptake is sensitive but NOT specific for malignancy. 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.